Stockreport

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

TransCode Therapeutics, Inc.  (RNAZ) 
PDF BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA [Read more]